Epidemiological, behavioural, and clinical factors associated with antimicrobial-resistant gonorrhoea: a review.

Szczegóły
Abstrakt

Tytuł:: Epidemiological, behavioural, and clinical factors associated with antimicrobial-resistant gonorrhoea: a review.
Autorzy:: Abraha M; Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland.
Egli-Gany D; Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland.
Low N; Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland.
Źródło:: F1000Research [F1000Res] 2018 Mar 27; Vol. 7, pp. 400. Date of Electronic Publication: 2018 Mar 27 (Print Publication: 2018).
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Original Publication: London : F1000 Research Ltd
References:: Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80. (PMID: 22155830)
Euro Surveill. 2017 Jan 5;22(1):. (PMID: 28079519)
Sex Transm Dis. 2014 Aug;41(8):501-6. (PMID: 25013979)
Am J Epidemiol. 1980 Dec;112(6):836-43. (PMID: 6893897)
Swiss Med Wkly. 2008 Apr 19;138(15-16):243-6. (PMID: 18431700)
J Infect Dis. 1999 Mar;179(3):729-33. (PMID: 9952388)
Future Microbiol. 2012 Dec;7(12):1401-22. (PMID: 23231489)
Sex Transm Dis. 1989 Jul-Sep;16(3):132-6. (PMID: 2510326)
PLoS Med. 2017 Jul 7;14 (7):e1002344. (PMID: 28686231)
J Infect Dis. 1989 May;159(5):900-7. (PMID: 2496174)
Sex Transm Dis. 2013 Jul;40(7):575-81. (PMID: 23965773)
Euro Surveill. 2009 Sep 17;14(37):null. (PMID: 19761737)
AIDS. 1994 Nov;8(11):1605-8. (PMID: 7848598)
BMC Infect Dis. 2017 Sep 11;17 (1):617. (PMID: 28893203)
Commun Dis Intell Q Rep. 2017 Mar 31;41(1):E. (PMID: 28385139)
Sex Transm Infect. 2017 Feb;93(1):39-45. (PMID: 27382010)
Emerg Infect Dis. 2011 Jan;17 (1):148-9. (PMID: 21192886)
Euro Surveill. 2017 May 18;22(20):null. (PMID: 28537548)
Emerg Infect Dis. 2017 Jan;23 (1):102-104. (PMID: 27983487)
AIDS Patient Care STDS. 2009 Aug;23(8):585-8. (PMID: 19591608)
Genitourin Med. 1997 Dec;73(6):518-21. (PMID: 9582473)
Euro Surveill. 2011 Feb 10;16(6):null. (PMID: 21329645)
Glob Health Action. 2017;10 (1):1330511. (PMID: 28598729)
J Antimicrob Chemother. 2014 May;69(5):1243-7. (PMID: 24379305)
Acta Derm Venereol. 2009;89(5):484-7. (PMID: 19734973)
Emerg Infect Dis. 2003 Dec;9(12):1654-6. (PMID: 14725311)
Lancet. 1976 Sep 25;2(7987):656-7. (PMID: 60518)
N Engl J Med. 2016 Jun 23;374(25):2504-6. (PMID: 27332921)
Emerg Infect Dis. 2016 Jan;22(1):88-91. (PMID: 26689861)
J Eur Acad Dermatol Venereol. 2007 Jul;21(6):818-21. (PMID: 17567314)
Sex Transm Dis. 2014 Dec;41(12):723-9. (PMID: 25581808)
PLoS One. 2015 Dec 08;10(12):e0143304. (PMID: 26646541)
BMC Public Health. 2016 Jul 07;16:525. (PMID: 27386950)
Lancet Infect Dis. 2013 Sep;13(9):762-8. (PMID: 23764300)
Clin Infect Dis. 2004 Aug 15;39(4):533-8. (PMID: 15356817)
PLoS One. 2014 Feb 19;9(2):e89458. (PMID: 24586792)
Lancet. 1976 Dec 25;2(8000):1379-82. (PMID: 63850)
Sex Transm Infect. 2004 Oct;80(5):379-85. (PMID: 15459406)
Euro Surveill. 2015;20(47):null. (PMID: 26625301)
CMAJ. 2009 Feb 3;180(3):287-90. (PMID: 19188626)
Clin Infect Dis. 2005 Sep 15;41(6):795-803. (PMID: 16107976)
Emerg Infect Dis. 2012 Aug;18(8):1290-7. (PMID: 22840274)
Clin Microbiol Rev. 2014 Jul;27(3):587-613. (PMID: 24982323)
Euro Surveill. 2012 Jun 21;17(25):null. (PMID: 22748003)
PLoS Pathog. 2016 May 19;12 (5):e1005611. (PMID: 27196299)
Sex Transm Dis. 2009 Oct;36(10):665-9. (PMID: 19704400)
Sex Transm Dis. 2004 Feb;31(2):73-8. (PMID: 14743069)
Sex Transm Infect. 2010 Feb;86(1):41-5. (PMID: 19703843)
Sex Transm Dis. 2004 Dec;31(12):702-8. (PMID: 15608583)
Int J Epidemiol. 1997 Dec;26(6):1373-85. (PMID: 9447420)
Antimicrob Agents Chemother. 2015 May;59(5):2588-95. (PMID: 25691638)
Enferm Infecc Microbiol Clin. 2018 Mar;36(3):165-168. (PMID: 28094065)
Contributed Indexing:: Keywords: Gonorrhoea; Neisseria gonorrhoeae; antimicrobial resistance; epidemiology; risk factors
Entry Date(s):: Date Created: 20180412 Latest Revision: 20220409
Update Code:: 20240104
PubMed Central ID:: PMC5871945
DOI:: 10.12688/f1000research.13600.1
PMID:: 29636908
: Czasopismo naukowe

Full Text Finder

Antimicrobial-resistant Neisseria gonorrhoeae is a global public health problem in the 21st century. N. gonorrhoeae has developed resistance to all classes of antibiotics used for empirical treatment, and clinical treatment failure caused by extensively resistant strains has been reported. Identifying specific factors associated with an increased risk of antimicrobial-resistant N. gonorrhoeae might help to develop strategies to improve antimicrobial stewardship. In this review, we describe the findings of 24 studies, published between 1989 and 2017, that examined epidemiological, behavioural, and clinical factors and their associations with a range of antimicrobial agents used to treat gonorrhoea. Antimicrobial-resistant N. gonorrhoeae is more common in older than younger adults and in men who have sex with men compared with heterosexual men and women. Antimicrobial-resistant N. gonorrhoeae is less common in some black minority and Aboriginal ethnic groups than in the majority white population in high-income countries. The factors associated with antimicrobial-resistant gonorrhoea are not necessarily those associated with a higher risk of gonorrhoea.
Competing Interests: No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

Informacja